Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disci/Rhus toxicodendron comp. in Chronic Low Back Pain
NCT00567736Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of discus intervertebralis + rhus toxicodendron in chronic low back pain (CLBP) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Visual Analogue Scale Low Back Pain at 8 weeks. Started Aug 2007; status: completed.
02
Drugs
discus intervertebralis + rhus toxicodendron
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00567736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567736.